Skip to content

Study · Ex vivo tissue · mouse · 1982

1 result

Stimulation of lymphocyte proliferation to monitor fractionation of thymus extracts.

Stepien H, Sakura N, Dahmen J, Lundanes E, Rampold G, Folkers K

Research communications in chemical pathology and pharmacology1 Sept 1982Cited by 7 (Europe PMC)

PMID7178652 (opens in a new tab)PepBankPUB-07178652
Publisher pageAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01LabEx vivo tissueActivity measurement

    In spleen cells from neonatally thymectomized mice, synthetic thymosin alpha‑1 was inactive in the [3H]-thymidine incorporation assay of lymphocyte proliferation.

    In plain wordsIn lab tests, synthetic thymosin alpha‑1 did not stimulate mouse spleen cell growth in this assay.

    Peptide
    Thymosin alpha-1
    Outcome
    No significant changeLymphocyte proliferation ([3H]-thymidine incorporation)
    Study

    mousen: not reported in source

    Spleen cells from neonatally thymectomized mice, [3H]-thymidine incorporation assay
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Calf thymus outer fraction ("CTO") showed activity, but Fraction 5, synthetic thymosin alpha 1, [G1n1]-FTS, and glutathione, were inactive in this assay.
    1 context sentence
    Summary · context
    The assay uses spleen cells from neonatally thymectomized mice as tissue relevant to immunoregulation.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 4Current

    21 Oct 2026, 12:50 UTC

    Study data updated · source update from Europe PMC

  2. Version 3

    10 Oct 2026, 08:55 UTC

    Study results updated

  3. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  4. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.